Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy clinical trial
The Blu Genes Foundation, a Toronto-based foundation dedicated to the development of gene therapy treatments for rare disease, has donated $1.4 million to UMass Medical School for the advancement of a Phase I/II clinical trial for the genetic disorder Tay-Sachs. The gift from the Blu Genes Foundation will be a catalyst in moving research from the […]
Blu Genes Foundation gives UMMS $1.4M to bring Tay-Sachs gene therapy clinical trial Read More »